Investigators conducted an individual patient data meta-analysis to assess the LSM-VCTE and compare it with the FIB-4 and NFS scores in order to develop diagnostic strategies that could reduce the need for liver biopsies.
The goal of this study was to determine the relationship between subclinical coronary artery disease and the severity of nonalcoholic fatty liver disease.
Researchers investigated the underlying mechanisms responsible for insulin resistance in patients with obesity and NAFLD.
Researchers reviewed the comorbidities associated with NAFLD across body systems and offered suggestions for facilitating a multidisciplinary care approach for these patients.
Investigators sought to determine if a relationship exists between nonalcoholic fatty liver and adipose tissue, waist-to-height ratio, and body mass index in patients with type 1 diabetes.
Investigators aimed to determine the metabolic and cardiovascular phenotypes of lean patients with NAFLD.
Investigators aimed to identify patients with high-risk NAFLD using noninvasive methods and link them to appropriate care.
Researchers evaluated the correlation of liver fibrosis and steatosis with diabetic peripheral neuropathy in patients with type 2 diabetes.
Investigators report results from MAESTRO-NAFLD-1, a phase 3, randomized, double-blind, placebo-controlled trial evaluating the effect of treatment with resmetirom in patients with hypothyroidism and nonalcoholic steatohepatitis.
Investigators examined the safety and efficacy of SGLT2i and GLP-1RA on treatment of nonalcoholic fatty liver disease in type 2 diabetes mellitus.
